B. Cakal Et Al. , "BAb and MxA as functional biomarkers in routine clinical laboratories for the determination of anti-IFN-beta antibodies and their bioactivity levels in multiple sclerosis patients.," Journal of immunoassay & immunochemistry , vol.35, pp.398-411, 2014
Cakal, B. Et Al. 2014. BAb and MxA as functional biomarkers in routine clinical laboratories for the determination of anti-IFN-beta antibodies and their bioactivity levels in multiple sclerosis patients.. Journal of immunoassay & immunochemistry , vol.35 , 398-411.
Cakal, B., Uygunoglu, U., SAIP, S., ALTINTAS, A., SIVA, A., & BADUR, S., (2014). BAb and MxA as functional biomarkers in routine clinical laboratories for the determination of anti-IFN-beta antibodies and their bioactivity levels in multiple sclerosis patients.. Journal of immunoassay & immunochemistry , vol.35, 398-411.
Cakal, Bülent Et Al. "BAb and MxA as functional biomarkers in routine clinical laboratories for the determination of anti-IFN-beta antibodies and their bioactivity levels in multiple sclerosis patients.," Journal of immunoassay & immunochemistry , vol.35, 398-411, 2014
Cakal, Bülent Et Al. "BAb and MxA as functional biomarkers in routine clinical laboratories for the determination of anti-IFN-beta antibodies and their bioactivity levels in multiple sclerosis patients.." Journal of immunoassay & immunochemistry , vol.35, pp.398-411, 2014
Cakal, B. Et Al. (2014) . "BAb and MxA as functional biomarkers in routine clinical laboratories for the determination of anti-IFN-beta antibodies and their bioactivity levels in multiple sclerosis patients.." Journal of immunoassay & immunochemistry , vol.35, pp.398-411.
@article{article, author={Bülent ÇAKAL Et Al. }, title={BAb and MxA as functional biomarkers in routine clinical laboratories for the determination of anti-IFN-beta antibodies and their bioactivity levels in multiple sclerosis patients.}, journal={Journal of immunoassay & immunochemistry}, year=2014, pages={398-411} }